Literature DB >> 27049496

Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression.

Adelaida Sara M Zepeda-Morales1, Susana Del Toro-Arreola2, Leonel García-Benavides3, Blanca E Bastidas-Ramírez1, Mary Fafutis-Morris2, Ana L Pereira-Suárez2, Miriam R Bueno-Topete1.   

Abstract

UNLABELLED: BACKGROUND AND RATIONALE FOR THE STUDY: IL-17, TGF-β1/2 are cytokines involved in the development of kidney, pulmonary and liver fibrosis. However, their expression kinetics in the pathogenesis of cholestatic liver fibrosis have not yet been fully explored. The aim of the study was to analyze the expression of IL-17, RORγt, NKp46, TGF-β1, and TGF-β2 in the liver of rats with bile duct ligation (BDL).
RESULTS: Hepatic IL-17A gene expression analyzed by qRT-PCR showed a dramatic increase of 350 and 10 fold, at 8 and 30 days post BDL, respectively. TGFβ1 and TGFβ2 gene expression significantly increased throughout the whole fibrotic process. At the protein level in liver homogenates, IL-17, TGF-β1, and RORγt significantly increased at 8 and 30 days after BDL. Interestingly, a significant increase in the protein levels of TGF-β2 and decrease of NKp46 was observed only 30 days after BDL. Unexpectedly, TGF-β2 exhibited stronger signals than TGF-β1 at the gene expression and protein levels. Histological analysis showed bile duct proliferation and collagen deposition.
CONCLUSIONS: Our results suggest that pro-fibrogenic cytokines IL-17, TGF-β1 and, strikingly, TGF-β2 might be important players of liver damage in the pathogenesis of early and advanced experimental cholestatic fibrosis. Th17 cells might represent an important source of IL-17, while NK cell depletion may account for the perpetuation of liver damage in the BDL model.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27049496     DOI: 10.5604/16652681.1198820

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  9 in total

1.  The TGFβ1 Receptor Antagonist GW788388 Reduces JNK Activation and Protects Against Acetaminophen Hepatotoxicity in Mice.

Authors:  Matthew McMillin; Stephanie Grant; Gabriel Frampton; Anca D Petrescu; Elaina Williams; Brandi Jefferson; Sharon DeMorrow
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

2.  Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.

Authors:  Kazuki Takahashi; Yuichi Akatsu; Katarzyna A Podyma-Inoue; Takehisa Matsumoto; Hitomi Takahashi; Yasuhiro Yoshimatsu; Daizo Koinuma; Mikako Shirouzu; Kohei Miyazono; Tetsuro Watabe
Journal:  J Biol Chem       Date:  2020-07-06       Impact factor: 5.157

Review 3.  Interleukin-17 pathways in systemic sclerosis-associated fibrosis.

Authors:  Sakir Ahmed; Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-05-09       Impact factor: 2.631

Review 4.  The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic?

Authors:  Silvia Bellando-Randone; Emanuel Della-Torre; Andra Balanescu
Journal:  J Scleroderma Relat Disord       Date:  2021-08-14

5.  Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.

Authors:  Xiao-Wei Zhang; Su Mi; Zhe Li; Ji-Chao Zhou; Jing Xie; Fang Hua; Ke Li; Bing Cui; Xiao-Xi Lv; Jiao-Jiao Yu; Zhuo-Wei Hu
Journal:  Oncotarget       Date:  2017-02-07

Review 6.  The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review).

Authors:  Suxia Bao; Jianming Zheng; Guangfeng Shi
Journal:  Mol Med Rep       Date:  2017-07-21       Impact factor: 2.952

7.  Microbiome alterations are related to an imbalance of immune response and bacterial translocation in BDL-rats.

Authors:  Natali Vega-Magaña; Antonio Galiana; Luis Felipe Jave-Suárez; Leonel Garcia-Benavides; Susana Del Toro-Arreola; Jaime Federico Andrade-Villanueva; Luz Alicia González-Hernández; Rosa Cremades; Adriana Aguilar-Lemarroy; María Guadalupe Flores-Miramontes; Jesse Haramati; Jesús Meza-Arroyo; Miriam Ruth Bueno-Topete
Journal:  Iran J Basic Med Sci       Date:  2020-02       Impact factor: 2.699

Review 8.  The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity.

Authors:  Mikhaïl A Van Herck; Jonas Weyler; Wilhelmus J Kwanten; Eveline L Dirinck; Benedicte Y De Winter; Sven M Francque; Luisa Vonghia
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

9.  Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.

Authors:  Shimaa Farouk; Salwa Sabet; Fatma A Abu Zahra; Akmal A El-Ghor
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.